secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0001193125-25-162939
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud

Verrica Pharmaceuticals Announces 1-for-10 Reverse Stock Split Effective July 24, 2025
--------------------------------------------------------------------------------

- Verrica Pharmaceuticals (VRCA) filed a Certificate of Amendment to effect a 1-for-10 reverse stock split, authorized by stockholders on June 5, 2025.
- The reverse stock split becomes effective at 5:00 p.m. ET on July 24, 2025; trading on Nasdaq on a split-adjusted basis begins July 25, 2025.
- Outstanding shares will be reduced from approximately 92.5 million to about 9.25 million, with no fractional shares issued; cash paid in lieu.
- Proportionate adjustments will be made to exercise price and number of shares issuable under stock options, warrants, and equity plans.
- The new CUSIP number for VRCA common stock post-split is 92511W207.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525162939/0001193125-25-162939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525162939/d30630d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-162939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer